1024829-73-9

Basic information

• Product Name: C₄₃H₆₃N₅O₉
• Synonyms: C₄₃H₆₃N₅O₉
• CAS NO: 1024829-73-9
• Molecular Weight: 794.001
• Mol File: 1024829-73-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₄₃H₆₃N₅O₉(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₃H₆₃N₅O₉(1024829-73-9)
• EPA Substance Registry System: C₄₃H₆₃N₅O₉(1024829-73-9)

Safety Data

• Hazardous Substances Data: 1024829-73-9(Hazardous Substances Data)

Upstream product

• 218962-73-3 D-Lys(Boc)-OAll hydrochloride 
• 1024829-72-8 (R)-2-((R)-2-((R)-2-tert-butyloxycarbonylamino-3-phenylpropanamido)-3-phenylpropanamido)-4-methylvaleric acid 

Downstream Products

• 1024829-76-2 (2R)-6-(tert-butoxycarbonylamino)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-(tert-butoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid 

Relevant articles and documents

Synthetic peptide amides

The invention relates to synthetic peptide amide ligands of the kappa opioid receptor and particularly to agonists of the kappa opioid receptor that exhibit low P450 CYP inhibition and low penetration into the brain. The synthetic peptide amides of the invention conform to the structure of formula I: Pharmaceutical compositions containing these compounds are useful in the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Such treatable pain includes visceral pain, neuropathic pain and hyperalgesia. Inflammation associated with conditions such as IBD and IBS, ocular and otic inflammation, other disorders and conditions such as pruritis, edema, hyponatremia, hypokalemia, ileus, tussis and glaucoma are treatable or preventable with the pharmaceutical compositions of the invention.